Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial

Autor: Di Giacomo, Anna Maria, Chiarion-Sileni, Vanna, Del Vecchio, Michele, Ferrucci, Pier Francesco, Guida, Michele, Quaglino, Pietro, Guidoboni, Massimo, Marchetti, Paolo, Simonetti, Elena, Santangelo, Federica, Amato, Giovanni, Covre, Alessia, Camerini, Roberto, Valente, Monica, Mandalà, Mario, Giannarelli, Diana, Calabrò, Luana, Maio, Michele
Zdroj: In European Journal of Cancer March 2024 199
Databáze: ScienceDirect
Externí odkaz: